Back to Results
First PageMeta Content
Antibiotics / Microbiology / Bacterial diseases / Infectious diseases / Glycopeptide antibiotics / Quinolone / Dalbavancin / Pathogenic bacteria / Ceftaroline fosamil / Medicine / Biology / Chemistry


PewLogo-Horizontal(white)
Add to Reading List

Document Date: 2014-08-19 12:16:07


Open Document

File Size: 134,21 KB

Share Result on Facebook

Company

Phase 2 Merck & Co. / Novartis / Phase 2 Theravance Inc. / The Medicines Company / Phase 1 Crestone Inc. / Phase 2 CrystalGenomics Inc. / Forest Laboratories / Phase 1 Rempex Pharmaceuticals / Cubist Pharmaceuticals / Medicines Co. / Furiex Pharmaceuticals Fluoroquinolone Brilacidin Phase 2 Cellceutix Corp. / GlaxoSmithKline / Actelion / Phase 1 Theravance Inc. / AstraZeneca / Phase 1 LegoChem Biosciences / Affinium Pharmaceuticals / Cempra Pharmaceuticals / Enanta Pharmaceuticals / MerLion Pharmaceuticals / Melinta Pharmaceuticals / MicuRx Pharmaceuticals / Tetraphase Pharmaceuticals / /

Continent

Europe / /

Country

Taiwan / United States / China / South Korea / /

Currency

VND / /

/

Event

FDA Phase / Second Stock Issuance / Business Partnership / /

Facility

Citeline’s Pharmaprojects Pipeline / Antibiotics NCE pipeline / /

IndustryTerm

biological products / qualified infectious disease products / /

MedicalCondition

mycobacterial infections / Pseudomonas / Community-acquired bacterial pneumonia / pneumonia/ventilator-associated pneumonia / prosthetic joint infections / serious infections / Bloodstream infections / Respiratory tract infections / skin structure infections / febrile neutropenia / qualified infectious disease / MicuRx Pharmaceuticals Oxazolidinone Bacterial infections / skin infections / acute intra-abdominal infections / urinary tract infections / cystic fibrosis / Complicated urinary tract infections / intra-abdominal infections / kidney infection / Gram-positive bacterial infections / infections / acute pyelonephritis / pneumonia / skin and skin structure infection / bacteremia / pulmonary infections / Bacterial infections / disease / bacterial pneumonia / diabetic foot infection / AstraZeneca DNA gyrase inhibitor Yes Gonococcal infections Aztreonam+Avibactam7 / diarrhea Hospital-acquired bacterial pneumonia / nosocomial pneumonia / serious bacterial infections / gonorrhea / Clinical Infectious Disease / tuberculosis / community-acquired respiratory infections / /

MedicalTreatment

Antibiotics / /

NaturalFeature

Forest Laboratories Monobactam / Forest Laboratories Cubist Pharmaceuticals Cephalosporin / Forest Laboratories Cephalosporin / /

Organization

Food and Drug Administration / Infectious Disease Society of America / Infectious Diseases Society of America / Centers for Disease Control and Prevention / /

Person

Rachel Zetts / /

/

Position

Governor / /

Product

Ceftazidime / CG-400549 / Generating Antibiotic / Eravacycline8 / TD-1792 / ACHN-975 / EDP-788 / Nemonoxacin9 / POL7080 / United States / GSK-1322322 / Plazomicin8 / AFN-1252 / CRS-3123 / BAL30072 / GSK-2696266 / Europe / AFN-1720 / MK-7655 / GSK-2140944 / Tazobactam8 / Avibactam7 / Fusidic acid / LCB01-0371 / 771 pro-drug / /

PublishedMedium

Clinical Microbiology Reviews / Nature Biotechnology / /

Technology

Biotechnology / ATM / AVI / http / drug development / /

URL

http /

SocialTag